Logo image
Insulin sensitization by small molecules enhancing GLUT4 translocation
Journal article   Open access   Peer reviewed

Insulin sensitization by small molecules enhancing GLUT4 translocation

Terry C Yin, Jonathan G Van Vranken, Dhiraj Srivastava, Ayushi Mittal, Paul Buscaglia, Autumn E Moore, Jissele A Verdinez, Aschleigh E Graham, Susan A Walsh, Michael A Acevedo, …
Cell chemical biology, Vol.30(8), pp.933-942.e6
08/2023
DOI: 10.1016/j.chembiol.2023.06.012
PMCID: PMC11191318
PMID: 37453421
url
https://pmc.ncbi.nlm.nih.gov/articles/PMC11191318/pdf/nihms-1998977.pdfView
Open Access

Abstract

Insulin resistance (IR) is the root cause of type II diabetes, yet no safe treatment is available to address it. Using a high throughput compatible assay that measures real-time translocation of the glucose transporter glucose transporter 4 (GLUT4), we identified small molecules that potentiate insulin action. In vivo, these insulin sensitizers improve insulin-stimulated GLUT4 translocation, glucose tolerance, and glucose uptake in a model of IR. Using proteomic and CRISPR-based approaches, we identified the targets of those compounds as Unc119 proteins and solved the structure of Unc119 bound to the insulin sensitizer. This study identifies compounds that have the potential to be developed into diabetes treatment and establishes Unc119 proteins as targets for improving insulin sensitivity.

Details

Logo image